Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Endocrinología y Nutrición (English Edition)
Uromastyx acanthinura as a natural treatment in a mouse model of type 2 diabetes
Yeray Brito-Casillas, Laura López-Ríos, Julia C. Wiebe, Clara Muñoz-Mediavilla, Francisco J. Nóvoa-Mogollón, Antonio Ojeda, Ana M. Wägner
10.1016/j.endoen.2016.01.005
Endocrinol Nutr 2016;63:13-8
Full text access
Lixisenatide clinical experience on patients with type 2 diabetes and obesity in endocrinology offices in Malaga
María del Mar Roca-Rodríguez, María José Tapia-Guerrero, Silvia Maraver-Selfa, Francisco José Tinahones, Isabel Mancha-Doblas
10.1016/j.endoen.2015.07.003
Endocrinol Nutr 2015;62:512-4
Full text access
Hyponatremic rhabdomyolysis in Addison's disease in a child with autoimmune polyglandular syndrome type 2
Elena Martín-Campagne, M. José Ballester-Herrera, Enrique Palomo-Atance, Prado Sánchez-Ruiz, Patricio Giralt-Muiña
10.1016/j.endoen.2015.07.002
Endocrinol Nutr 2015;62:511-2
Full text access
Therapeutic education and self-care: Results from the cross-sectional study Diabetes, Attitudes, Wishes and Needs 2 (DAWN2) in Spain
Mercedes Galindo Rubio, Margarida Jansà Morató, Edelmiro Menéndez Torre
10.1016/j.endoen.2015.10.008
Endocrinol Nutr 2015;62:391-9
Full text access
What's new in heart failure in the patient with type 2 diabetes?
Miguel Camafort
10.1016/j.endoen.2015.09.002
Endocrinol Nutr 2015;62:350-5
Full text access
Glycemic control parameters in insulin-naïve patients with uncontrolled type 2 diabetes referred to endocrinologists, and degree of implementation of the national Spanish consensus for the management of hyperglycemia
Sharona Azriel, Florentino Casal, Belén Dalama, Francisco Varillas, África Villarroel, Alfonso Soto, Gloria Barberá
10.1016/j.endoen.2014.11.004
Endocrinol Nutr 2014;61:541-7
Full text access
Impact of “Conversation Map™” tools on understanding of diabetes by Spanish patients with type 2 diabetes mellitus: A randomized, comparative study
Maite Penalba, Luis Moreno, Amelia Cobo, Jesús Reviriego, Angel Rodríguez, Simon Cleall, Matthew Reaney
10.1016/j.endoen.2014.11.003
Endocrinol Nutr 2014;61:505-15
Full text access
A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients
Francisco J. Ampudia-Blasco, Manuel Galán, Meryl Brod
10.1016/j.endoen.2014.07.003
Endocrinol Nutr 2014;61:426-33
Full text access
Clinical course after five years of insulin therapy in patients with type 2 diabetes in Spain: Results of the EDIN study
Angel Rodríguez, Santiago Tofe, Jesus Reviriego
10.1016/j.endoen.2014.06.011
Endocrinol Nutr 2014;61:369-76
Full text access
Do we need new treatments for type 2 diabetes?
Fernando Gomez-Peralta, Cristina Abreu Padín
10.1016/j.endoen.2014.06.002
Endocrinol Nutr 2014;61:323-8
Full text access
Special content about COVID-19
- Gut microbiota and type 2 diabetes mellitus
- Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)
- Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
- Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Publication History